1 State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, People's Republic of China.
2 Department of Pharmacy, Shaheed Benazir Bhutto University, Sheringal, Dir, 18000, KP, Pakistan.
3 Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, KP, Pakistan.
4 Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-Cerebrovascular Diseases, Jinan University College of Pharmacy, Guangzhou, 510632, People's Republic of China.
5 Cancer Centre, The Second Hospital of Shandong University, Jinan, People's Republic of China. jiangyuhua@sdu.edu.cn.
6 State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, People's Republic of China. lisp@pku.edu.cn.
7 Campbell Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. lisp@pku.edu.cn.